{"id":"W2892018897","doi":"10.1016/j.phrs.2018.09.007","title":"Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug","year":2018,"lang":"en","type":"article","venue":"Pharmacological Research","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":99,"is_retracted":false,"has_abstract":true,"ca_institutions":"Children's Hospital of Eastern Ontario; Alberta Children's Hospital; University of Calgary","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Neurological Disorders and Stroke; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Muscular Dystrophy Association; U.S. Department of Defense","keywords":"Pharmacodynamics; Duchenne muscular dystrophy; Medicine; Pharmacology; Pharmacokinetics; Drug; Internal medicine; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001060752,0.0006214556,0.00105609,0.0002321003,0.0002869824,0.0005891804,0.000356857,0.001054707,0.00244501],"category_scores_gemma":[0.0006862699,0.0002020073,0.0005713258,0.0001777118,0.00045948,0.000306577,0.0001828941,0.001563839,0.0005199212],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00039344,"about_ca_system_score_gemma":0.0004498181,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004732443,"about_ca_topic_score_gemma":0.002108966,"domain_scores_codex":[0.9995491,0.0002404264,0.00002762248,0.00006177865,0.0000445935,0.00007649371],"domain_scores_gemma":[0.9993849,0.0002149654,0.0001325122,0.00004876659,0.00003972201,0.0001791621],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2351466,0.04474243,0.02008273,0.00209368,0.001774091,0.001342227,0.0007281217,0.003196636,0.354413,0.0006746245,0.004559612,0.3312462],"study_design_scores_gemma":[0.1300798,0.805773,0.02889254,0.0001058782,0.0003896558,0.001074283,0.00009895647,0.001008664,0.02379931,0.0001704008,0.008557182,0.00005043369],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920407,0.004091841,0.0005516608,0.0002977202,0.00007086548,0.0006552439,0.000352832,0.00006059949,0.001878542],"genre_scores_gemma":[0.9929046,0.00141083,0.001411837,0.0005403425,0.00009983622,0.0003744213,0.0005922763,0.00001353369,0.002652421],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00244501,"threshold_uncertainty_score":0.008179367,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05312323704595653,"score_gpt":0.412047690765389,"score_spread":0.3589244537194325,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}